【摘要】：目的比較鼻咽癌患者調(diào)強(qiáng)放射治療與常規(guī)二維放射治療的療效和急慢性反應(yīng)。 方法系統(tǒng)分析2008年5月至2010年12月在福建醫(yī)科大學(xué)附屬第一醫(yī)院放射治療科同期常規(guī)放射治療及調(diào)強(qiáng)放射治療(IMRT)的初治鼻咽癌患者203例，分為IMRT組（103例）和常規(guī)放射治療組（100例）。常規(guī)放射治療鼻咽部劑量66～74Gy，腫大淋巴結(jié)64—68Gy，頸部預(yù)防劑量50-52Gy；調(diào)強(qiáng)放射治療設(shè)鼻咽大體腫瘤為GTVnx、頸部陽(yáng)性淋巴結(jié)GTVnd，高危臨床靶體積CTV1和低危臨床靶體積CTV2：。PTVnx：70.08土1.81Gy，PTVnd：67.38土2.58Gy，PTVl：61.46土2.13Gy，，PTV2：54.12土2.04Gy，分31～33次照射。比較IMRT和常規(guī)放射治療患者的急性不良反應(yīng)如口干、吞咽疼痛、吞咽困難、皮膚和黏膜反應(yīng)等；晚期損傷中張口困難、肌肉/軟組織損傷等方面。 結(jié)果與常規(guī)組相比，IMRT組的急性不良反應(yīng)有不同程度的減輕，口干、吞咽疼痛、吞咽困難、皮膚反應(yīng)和黏膜反應(yīng)等的發(fā)生率較低(P＜0.05)；晚期損傷中張口困難、肌肉/軟組織損傷無(wú)明顯差別。 結(jié)論相對(duì)于常規(guī)放射治療，IMRT技術(shù)能夠減輕急性不良反應(yīng)，改善患者的生存質(zhì)量。
[Abstract]:Objective to compare the efficacy and acute and chronic response of intensity modulated radiotherapy and conventional two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Methods from May 2008 to December 2010, 203 patients with nasopharyngeal carcinoma (NPC) who were treated with conventional radiotherapy and intensity modulated radiotherapy (IMRT) in the Department of radiotherapy, first affiliated Hospital of Fujian Medical University were analyzed systematically. The patients were divided into IMRT group (103 cases) and conventional radiotherapy group (100 cases). The dose of nasopharynx was 660.74 Gy, the enlarged lymph node 64-68 Gy, and the cervical preventive dose 50-52 Gy. Intensity modulated radiotherapy (IMRT) for nasopharyngeal gross neoplasms: GTVnx, neck positive lymph node GTVnd, high risk target volume CTV1 and low risk clinical target volume CTV2:.PTVnx:70.08 1. 81Gy: 67.38 鹵2.58Gy PTVl: 61.46 鹵2.13Gy PTV2: 54.12 鹵2.04Gy, 3133 exposures. The acute adverse reactions such as dry mouth, dysphagia, skin and mucosal reaction in patients with IMRT and conventional radiotherapy were compared. Results compared with the control group, the incidence of acute adverse reactions in the IMRT group was lower than that in the control group (P < 0.05), and the incidence of dry mouth, dysphagia, skin reaction and mucosal reaction was lower (P < 0.05), and it was difficult to open the mouth in the late stage injury. There was no significant difference in muscle / soft tissue injury. Conclusion compared with conventional radiotherapy, IMRT can alleviate acute adverse reactions and improve the quality of life of patients.
【學(xué)位授予單位】：福建醫(yī)科大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2012
【分類號(hào)】：R739.63

【參考文獻(xiàn)】

相關(guān)期刊論文 前9條

1 陳明,曾祥發(fā),趙充,吳少雄,黃曉延,韓非,羅偉,盧泰祥,崔念基;鼻咽癌患者放療后張口困難及其影響因素[J];癌癥;2001年06期

2 潘建基;林少俊;張瑜;陳傳本;鄭茁;鄭葳;;鼻咽癌調(diào)強(qiáng)放療初步結(jié)果[J];中華腫瘤防治雜志;2006年20期

3 宋鑫;李莉;馬曉殙;楊金艷;;鼻咽癌治療性抗體和小分子化合物研究進(jìn)展[J];腫瘤學(xué)雜志;2008年01期

4 張偉;李國(guó)平;辛海燕;;腫瘤放療新技術(shù)——容積弧形調(diào)強(qiáng)放射治療技術(shù)[J];中國(guó)醫(yī)療設(shè)備;2011年12期

5 肖澤民;廖遇平;姜武忠;吳濤;;調(diào)強(qiáng)適形放療對(duì)腮腺功能的保護(hù)[J];中國(guó)耳鼻咽喉顱底外科雜志;2007年02期

6 戴建榮;胡逸民;;圖像引導(dǎo)放療的實(shí)現(xiàn)方式[J];中華放射腫瘤學(xué)雜志;2006年02期

7 趙充;盧麗霞;韓非;盧泰祥;黃劭敏;林承光;鄧小武;崔念基;;122例鼻咽癌單純根治性調(diào)強(qiáng)放療療效分析[J];中華放射腫瘤學(xué)雜志;2006年05期

8 姜鋒;陳曉鐘;魏?jiǎn)⒋?;鼻咽癌放療技術(shù)的歷史發(fā)展[J];中國(guó)腫瘤;2009年08期

9 吳毅;;外科手術(shù)在鼻咽癌治療中的作用[J];中華臨床醫(yī)師雜志(電子版);2009年09期

本文編號(hào)：2255012